Driving on ice: Impaired driving skills in current methamphetamine users

Psychopharmacology

Volumn 225, Issue 1, 2013, Pages 161-172

  Bosanquet, David ^a   MacDougall, Hamish G ^a   Rogers, Stephen J ^a   Starmer, Graham A ^b   McKetin, Rebecca ^c   Blaszczynski, Alexander ^a   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Antisocial; Driving; Impulsivity; Methamphetamine; Risk; Simulator

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; METHAMPHETAMINE; OPIATE; PSYCHEDELIC AGENT; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRIVING ABILITY; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG SALIVA LEVEL; FEMALE; HIGH RISK BEHAVIOR; HUMAN; IMPULSIVENESS; MALE; METHAMPHETAMINE DEPENDENCE; PERSONALITY; PRIORITY JOURNAL; PSYCHOPATHY; SIMULATION; SOMNOLENCE; TASK PERFORMANCE; TRAFFIC ACCIDENT; VELOCITY;

ACCIDENTS, TRAFFIC; ADULT; AMPHETAMINE-RELATED DISORDERS; AUTOMOBILE DRIVING; CASE-CONTROL STUDIES; COMPUTER SIMULATION; FEMALE; HUMANS; ICE; MALE; METHAMPHETAMINE; MIDDLE AGED;

EID: 84872360457     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2805-y     Document Type: Article

References (62)

1. Åkerstedt T, Gillberg M (1990) Subjective and objective sleepiness in the Active Individual. Int J Neurosci 52:29-37
2. Augsburger M, Donze N, Menetrey A, Brossard C, Sporkert F, Giroud C, Mangin P (2005) Concentration of drugs in blood of suspected impaired drivers. Forensic Sci Int 153:11-15
3. Barkley RA, Murphy KR, O'Connell T, Anderson D, Connor DF (2006) Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/hyperactivity disorder. Neuropsychology 20(1):77-87
4. Baskin-Sommers A, Sommers I (2006) The co-occurrence of substance use and high-risk behaviours. J Adolesc Health 38:609-611
5. Boorman SM, Papafotiou K (2007) The Victorian legislative framework for testing drivers for impairment caused by drugs other than alcohol: an evaluation of the characteristics of drivers tested from 2000 to 2005. Traffic Inj Prev 8:217-223
6. Cornish JL, Clemens, KJ, Thompson MR, Callaghan PD, Dawson B, McGregor IS (2008) High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats. J Psychopharmacol (Oxf) 22:100-110
7. Couper FJ, Logan BK (2004) Drugs and human performance facts sheet. National Highway Traffic Safety Administration (NHTSA), US Department of Transportation Report Number: DOT HS 809 725
8. Cox DJ, Merkel RL, Kovatchev B, Seward R (2000) Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis 188(4):230-234
9. Cruikshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085-1099
10. Degenhardt L, Topp L (2003) "Crystal meth" use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harm. Int J Drug Policy 14:17-24
11. Degenhardt L, Dillon P, Duff C, Ross J (2006) Driving, drug use behaviour and risk perceptions of nightclub attendees in Victoria, Australia. Int J Drug Policy 17:41-46
12. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JRM, Robertson MD, Swann P (2003) The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 134:154-162
13. Emonson DL, Vanderbeek RD (1995) The use of amphetamines in US Air-force tactical operations during desert shield and storm. Aviat Space Environ Med 66:260-263
14. Fals-Stewart W, O'Farrell TJ, Freitas TT (2000) The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68:133-144
15. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of the patients for the clinician. J Psychiatr Res 12:189-198
16. Gorlyn M, Keilp JG, Tryon WW, Mann JJ (2005) Performance test correlates of component factors of impulsiveness. Pers Individ Dif 38:1549-1559
17. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Krüger HP, Longo M (2007) Developing limits for driving under cannabis. Addiction 102(12):1910-1917
18. Homer BD, Solomon TM, Moeller RW, Mascia A, DeRaleau L, Halkitis PN (2008) Methamphetamine abuse and impairment in social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol Bull 134:565-567
19. Johnson BA, Ait-Daoud N, Wells LT (2000) Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology 22(5):504-512
20. Jones AW, Holmgren A (2005) Abnormally high concentrations of amphetamine in blood of impaired drivers. J Forensic Sci 50:1-6
21. Kaye S, Darke S, Duflou J, McKetin R (2008) Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction 103:1353-1360
22. Kelly TH, Foltin RW, Fischman MW (1991) The effects of repeated amphetamine exposure on multiple measures of human behavior. Pharmacol Biochem Behav 38:417-426
23. Kloeden CN, McLean AJ, Moore VM, Ponte J (1997) Travelling speed and the risk of crash involvement. Volume 1 - findings. CR 172. Federal Office of Road Safety, Canberra
24. Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA (2008) Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 30:320-332
25. Krasnova IN, Cadet JL, Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379-407
26. Lapworth K, Dawe S, Davis P, Kavanagh D, Young R, Saunders J (2009) Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. Addict Behav 34:380-385
27. Lecrubier Y, Sheehan DV, Weiller E (1997) The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12:224-231
28. Liguori A (2009) Simulator studies of drug induced driving impairment. In: Verster JC, Pandi-Perumal SR, Ramaekers JG, De Gier JJ (eds) Drugs, driving and traffic safety. Birkhauser, Switzerland
29. Logan BK, Schwilke EW (1996) Drug and alcohol use in fatally injured drivers in Washington State. J Forensic Sci 41(3):505-510
30. Logan BK, Fligner CL, Haddix T (1998) Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci 43(1):28-34
31. Louwerens JW, Gloerich ABM, de Vries G, Brookhuis K, O'Hanlon JF (1987) The relationship between driver's blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R (eds) Alcohol, drugs and traffic safety: proceedings of the 10th International Conference on Alcohol, Drugs and Traffic Safety. Excerpta Medica, Amsterdam, pp 183-192
32. Mancino MJ, Gentry BW, Feldman Z, Mendelson J, Oliveto A (2011) Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse 37:131-136
33. Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J, Cami J (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290:136-145
34. Maxwell JC (2005) Emerging research on methamphetamine. Curr Opin Psychiatr 18:235-242
35. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM (2005) The nature, time course and severity of methamphetamine withdrawal. Addiction 100(9):1320-1329
36. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ (2005) Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 13(3):141-154
37. Mitler MM, Hajdukovic R, Erman MK (1993) Treatment of narcolepsy with methamphetamine. Sleep 16(4):306-317
38. O'Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of a new test. Br J Clin Pharmacol 18:S121-S132
39. Paaver M, Eensoo D, Pulver A, Harro J (2006) Adaptive and maladaptive impulsivity, platelet monoamine oxidase (MAO) activity and risk-admitting in different types of risky drivers. Psychopharmacology (Berl) 186:32-40
40. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51:568-774
41. Pennay AE, Lee NK (2010) Putting the call out for more research: the poor evidence base for treating methamphetamine withdrawal. Drug Alcohol Rev 30:216-222
42. Ramaekers JG, Kuypers KPC, Samyn N (2006) Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. Addiction 101(11):1614-1621
43. Ramaekers JG, Berghaus G, van Laar MW, Drummer OH (2009) Dose related risk of motor vehicle crashes after cannabis use: an update. In: Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ (eds) Drugs, driving and traffic safety. Birkhauser, Switzerland
44. Rapoport JL, Banina MC (2007) Impact of psychotropic medications on simulated driving - a critical review. CNS Drugs 21:503-519
45. Richards JB, Sabool KE, de Wit H (1999) Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology (Berl) 146:432-439
46. Ryb GE, Dischinger PC, Kufera JA, Read KM (2006) Risk perception and impulsivity: association with risky behaviors and substance abuse disorders. Accid Anal Prev 38:567-573
47. Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, Mori N, Gold MS, Cadet JL (2008) Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28:5756-5761
48. Shappell SA, Kearns GL, Valentine JL, Neri DF, DeJohn CA (1996) Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol 36:1051-1063
49. Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A (2009) A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction 104:224-233
50. Sheehan DV, Lecrubier Y, Harnett-Sheehan K (1998) The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychol 59(Suppl 20):22-33
51. Silber BY, Croft RJ, Papafotiou K, Stough CK (2006) The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology (Berl) 187:154-169
52. Silber BY, Croft RJ, Downey LA, Camfield DA, Papafotiou K, Swann P, Stough C (2012) The effect of d,l-methamphetamine on simulated driving performance. Psychopharmacology (Berl) 219:1081-1087
53. Stough C, Downey LA, King R, Papafotiou K, Swann PEO (2012) The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study. Accid Anal Prev 45:493-497
54. Suzanne GD, Fatovich DM, McCoubrie DL, Daly FF (2007) Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 186:336-339
55. Tombaugh TN, McIntyre NJ (1992) The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 40:922-935
56. Vassallo S, Smart D, Sanson A, Cockfield S, Harris A, McIntyre A, Harrison W (2008) Risky driving among young Australian drivers II: co-occurrence with other problem behaviours. Accid Anal Prev 40:376-386
57. Vermeeren A, Leufkens T, Verster JC (2009) Effects of anxiolytics on driving. In: Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ (eds) Drugs, driving and traffic safety. Birkhauser, Switzerland
58. Verster JC, Roth T (2011) Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med 4:359-371
59. Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M (2010) Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 65:135-142
60. Walburga M, Laar V, Volkerts ER, Van Paul WAP (1992) Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. J Clin Psychopharmacol 12:86-95
61. Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122(2-3):107-123
62. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, Rawson R, London ED (2010) Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction 105:1809-1818